Antidiabetic potentials of momordica charantia: Multiple mechanisms behind the effects

Journal of Medicinal Food

Volumn 15, Issue 2, 2012, Pages 101-107

  Chaturvedi, Padmaja ^a  

^a UNIVERSITY OF BOTSWANA   (Botswana)

Author keywords

a glucosidase; antihyperlipidemic effect; antioxidant activity; blood glucose; diabetes; insulin resistance; Momordica charantia

Indexed keywords

ADIPONECTIN; AGLYCONE; ALKALOID DERIVATIVE; ASCORBIC ACID; CHARANTIN; CUCURBITACIN GLYCOSIDE; CUCURBITANE GLYCOSIDE; DISACCHARIDASE; FATTY ACID; GLUCOSE; GLUCOSIDASE; GLYCOSIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; KARAVILOSIDE XI; MOMORDICA CHARANTIA EXTRACT; MOMORDICIN; MOMORDIN; NITROGEN; PHENOL; PLANT GLYCOSIDE; POTASSIUM; STEROL; TANNIN; THYROID HORMONE; THYROXINE; TRITERPENOID; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN; UNINDEXED DRUG; VEGETABLE PROTEIN;

ADIPOSE TISSUE; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; CELL DAMAGE; CELL REGENERATION; CHEMICAL COMPOSITION; DIABETES MELLITUS; DIET RESTRICTION; DIGESTIVE SYSTEM; DRUG EFFICACY; DRUG MECHANISM; DRUG SOLUBILITY; ENZYME ACTIVITY; ENZYME INHIBITION; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; FRUIT JUICE; GLUCOSE ABSORPTION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERLIPIDEMIA; HYPOGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; INTESTINE; LIPOGENESIS; MITOCHONDRION; MOMORDICA CHARANTIA; NONHUMAN; OBESITY; PANCREAS; PANCREAS ISLET BETA CELL; PHYTOCHEMISTRY; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; STREPTOZOCIN DIABETES; THYROID HORMONE RELEASE; THYROID HORMONE SYNTHESIS;

ANIMALS; DIABETES MELLITUS; GLUCOSE; HUMANS; HYPOGLYCEMIC AGENTS; MOMORDICA CHARANTIA; PLANT EXTRACTS;

ANIMALIA; MOMORDICA CHARANTIA;

EID: 84856295936     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2010.0258     Document Type: Review

References (73)

1. Heilbronn L, Smith SR, Ravussin E: Function of fat cell proliferation, mitochondrial function and fat oxidation results in ec-topic fat storage, insulin resistance and type II diabetes. Int J Obes Relat Metab Disord 2004;28(Suppl 4):S12-S21. (Pubitemid 40143844)
2. Shepherd J: Dyslipidaemia in diabetic patients: time for a rethink. Diabetes Obes Metab 2007;9:609-616. (Pubitemid 47261843)
3. Reusch JE, Draznin BB: Atherosclerosis in diabetes and insulin resistance. Diabetes Obes Metab 2007;9:455-463. (Pubitemid 47022828)
4. Peerapatdit T, Likidlilid A, Patchanans N, Somkasterin A: An-tioxidant status and lipid peroxidation endproducts in patients of type 1 diabetes mellitus. J Med Assoc Thai 2006;89(Suppl 5): S141-S146. (Pubitemid 46193143)
5. Grover JK, Yadav SP: Pharmacological actions and potential uses of Momordica charantia: a review. J Ethnopharmacol 2004;93:123-132. (Pubitemid 38739282)
6. Sathishekar D, Subramanian S: Antioxidant properties of Mo-mordica charantia (bitter gourd) seeds on streptozotocin induced diabetic rats. Asia Pac J Clin Nutr 2005;14:153-158. (Pubitemid 40769784)
7. Basch E, Gabardi S, Ulbricht C: Bitter melon (Momordica charantia): a review of efficacy and safety. Am J Health Syst Pharm 2003;60:356-359. (Pubitemid 36749034)
8. Wong CM, NGTB, Yeung HW: Screening of Trichosanthes kirilowi, Momordica charantia and Cucurbita maxima for compound with antilipolytic activity. J Ethnopharmacol 1985;13: 312-332.
9. Tongia A, Tongia SK, Mangala D: Phytochemical determination and extraction of Momordica charantia fruit and its hypoglyce-mic potentiation of oral hypoglycemic drugs in diabetes mellitus. Indian J Physiol Pharmacol 2004;48:241-244. (Pubitemid 38436928)
10. Chang CI, Chen CR, Liao YW, Cheng HL, Chen YC, Chou CH: Cucurbitane type triterpenoids from Momordica charantia. J Nat Prod 2006;69:1168-1171.
11. Liva H, Michi T, Shigeru T, Munehiro O, Orie M, Masayuki U, Yeshinori A: Momordica charantia constituents and antidiabetic screening of the isolated major compounds. Chem Pharm Bull 2006;54:1017-1021.
12. Tan MJ, Ye JM, Turner N, Honen-Behrens C, Ke CQ, Tang CP, Chen T, Weiss HC, Gesing ER, Rowland A, James DE, Ye Y: Antidiabetic activities of triterpenoids isolated from bitter melon associated with the activation of AMPK pathway. Chem Biol 2008;15:263-273. (Pubitemid 351381992)
13. Assubaie NF, El-Garawany MM: Evaluation of some important chemical constituents of Momordica charantia cultivated in Hofuf, Saudi Arabia. J Biol Sci 2004;4:628-630.
14. Akhtar MS, Athar MA, Yaqub M: Effect of Momordica char-antia on blood glucose level of normal and alloxan-diabetic rabbits. Planta Med 1981;42:205-212. (Pubitemid 11007849)
15. Leatherdale BA, Panesar RK, Atkins TW, Bailey CJ, Bignell AH: Improvement in glucose tolerance due to Momordica charantia (karela). Br Med J (Clin Res Ed) 1981;282:1823-1824. (Pubitemid 11047735)
16. Higashino H, Suzuki A, Tanaka Y, Pootakham K: Hypogly-cemic effects of Siamese Momordica charantia and Phyllanthus urinaria extracts in streptozotocin-induced diabetic rats (the 1st report). Nippon Yakurigaku Zasshi 1992;100:415-421. (Pubitemid 23010885)
17. Sarkar S, Pranav M, Marita R: Demonstration of the hypogly-cemic action of Momordica charantia in a validated animal model of diabetes. Pharmacol Res 1996;33:1-4. (Pubitemid 26229602)
18. Day C, Cartwright T, Provost J, Bailey CJ: Hypoglycaemic effect of Momordica charantia extracts. Planta Med 1990;56: 426-429. (Pubitemid 20347576)
19. Chaturvedi P, Kamau GN, Cheruiyot R, Tripathi YB: Hypogly-cemic and hyperglycemic responses of Momordica charantia. Int J Biochem Phys 2003;11:1-6.
20. Chaturvedi P, Akala H: Assessment of thyrogenic responses of M. charantia. J Appl Zool Res 2003;14:193-197.
21. Nerurkar PV, Lee YK, Motosue M, Adeli K, Nerurkar VR: Mo-mordica charantia (bitter melon) reduces plasma apolipoprotein B-100 and increases hepatic insulin receptor substrate and phos-phoinositide-3 kinase interactions. Br J Nutr 2008;5:1-9.
22. Singh N, Tyagi SD, Agarwal SC: Effects of long term feeding of acetone extract of Momordica charantia (whole fruit powder) on alloxan diabetic albino rats. Indian J Physiol Pharmacol 1989; 33:97-100. (Pubitemid 19200419)
23. Ojewole JA, Adewole SO, Olayiwola G: Hypoglycaemic and hypotensive effects of Momordica charantia Linn (Cucurbitaceae) whole-plant aqueous extract in rats. Cardiovasc J S Afr 2006;17:227-232. (Pubitemid 46089124)
24. Vikrant V, Grover JK, Tendon N, Rathi SS, Gupta N: Treatment with extracts of Momordica charantia and Eugenia jambolana prevents hyperglycemia and hyperinsulinemia in fructose fed rats. J Ethnopharmacol 2001;76:139-143. (Pubitemid 32487619)
25. Ahmad N, Hassan MR, Haldar H: Effect of Momordica char-antia (Karolla) extracts on fasting and postprandial serum glucose levels in NIDDM patients. Bangladesh Med Res Coun Bull 1999;25:11-13.
26. Welihinda J, Karunanayake EH, Sheriff MH, Jayasinghe KS: Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes. J Ethnopharmacol 1986;17:277-282. (Pubitemid 17209188)
27. Senanayake GV, Maruyama M, Shibuya K, Sakono M, Fukuda N, Morishita T, Yukizaki C, Kawano M, Ohta H: The effects of bitter melon (Momordica charantia) on serum and liver triglyc-eride levels in rats. J Ethnopharmacol 2004;91:257-262. (Pubitemid 38561123)
28. Chaturvedi P, George S, Miliganyo M, Tripathi YB: Effect of Momordica charantia on lipid profile and oral glucose tolerance in diabetic rats. Phytother Res 2004;18:954-956. (Pubitemid 40052780)
29. Jayasooriya AP, Sakono M, Yukizaki C, Rawano M, Yamamoto K, Fukuda N: Effects of Momordica charantia powder on serum glucose levels and various lipid parameters in rats fed with cholesterol-free and cholesterol-enriched diets. J Ethnopharma-col 2000;72:331-336.
30. Chaturvedi P: Role of Momordica charantia in maintaining the normal levels of lipids and glucose in diabetic rats fed a high-fat and low-carbohydrate diet. Br J Biomed Sci 2005;62: 124-126. (Pubitemid 41603067)
31. +-adenosine triphosphate activity and gene expression in experimental diabetes mellitus. Dig Dis Sci 1999;44:407-414. (Pubitemid 29093569)
32. Mahmoodally MF, Gurib-Fakin A, Subratty AH: Momordica charantia extracts inhibit uptake of monosaccharides and amino acids across rat everted gut sacs in vitro. Biol Pharm Bull 2004; 27:216-218. (Pubitemid 41694701)
33. Ahmad I, Adeghate E, Cuminmgs E, Sharma AK, Singh J: Beneficial effects and mechanism of action of Momordica charantia juice in the treatment of streptozotocin induced diabetes mellitus in rats. Mol Cell Biochem 2004;261:63-70. (Pubitemid 39004517)
34. Varro V, Jung I, Szarvas F, Csernay L: Glucose absorption in relation to ATP content of the small-intestine mucosa in the dog. Dig Dis Sci 1965;10:178-182.
35. Mahmoodally MF, Gurib-Fakin A, Subratty AH: Effects of exogenous ATP on Momordica charantia Linn (Cucurbitaceae) induced inhibition of d-glucose, l-tyrosine and fluid transport across rat everted intestinal sacs in vitro. J Ethnopharmacol 2007;110:257-263. (Pubitemid 46283659)
36. Dyer J, Wood IS, Palejwala A, Ellis A, Shirazi-Beechey SP: Expression of monosaccharide transporters in intestine of diabetic humans. Am J Gastrointest Liver Physiol 2002;261: 63-70.
37. Casirola DM, Ferraris RP: a-Glucosidase inhibitors prevent diet-induced increases in intestinal sugar transport in diabetic mice. Metabolism 2006;55:832-841.
38. Anila L, Vijayalakshmi NR: Beneficial effects of flavonoids from Sesmum indicum, Embilica officinalis and Momordica charantia. Phytother Res 2000;14:592-595.
39. Matsura H, Asakawa C, Kurimoto M, Mizutani J: a-Glucosidase inhibitor from the seeds of balsam peer (Momordica charantia) and the fruit bodies of Grifola fiondosa. Biosci Biotechnol Bio-chem 2002;66:1576-1578. (Pubitemid 39246868)
40. Kumar Shetty A, Suresh Kumar G, Veeraya Salimath P: Bitter gourd (Momordica charantia) modulates activities of intestinal and renal disaccharidases in streptozotocin-induced diabetic rats. Mol Nutr Food Res 2005;49:791-796.
41. Uebanso T, Arai H, Taketani Y, Fukaya M, Yamamoto H, Mi-zuno A, Uryu K, Hada T, Takeda E: Extracts of Momordica charantia suppress postprandial hyperglycemia in rats. J Nutr Sci Vitaminol (Tokyo) 2007;53:482-488. (Pubitemid 351154868)
42. Oishi Y, Sakamoto T, Udagawa H, Taniguchi H, Kobayashi-Hattori K, Ozawa Y, Takita T: Inhibition of increase in blood glucose and serum neutral fat by Momordica charantia saponin fraction. Biosci Biotechnol Biochem 2007;71:735-740. (Pubitemid 46481449)
43. Miura T, Itoh C, Iwamoto N, Kato M, Kawai M, Park SR, Suzuki I: Hypoglycemic activity of the fruit of the Momordica charantia in type 2 diabetic mice. J Nutr Sci Vitaminol (Tokyo) 2001; 47:340-344. (Pubitemid 33139560)
44. Sirintorn YA, Sisrchai A, Cheng Yu Y, Polkit S, Sophon R, Walter HH: Slow acting protein extract from fruit pulp of Mo-mordica charantia with insulin secretagogue and insulin mimetic activities. Biol Pharm Bull 2006;29:1126-1131.
45. Roffey BW, Atwal AS, Johns T, Kubow S: Water extracts from Momordica charantia increases glucose uptake and adiponectin secretion from adipocytes in 3T3-L1 adipose cells. J Ethno-pharmacol 2007;112:77-84. (Pubitemid 46702417)
46. Cuming E, Hundal S, Wackerhage H, Hope M, Belk M, Ade-ghate E, Singh J: Momordica charantia fruit juice stimulates glucose and amino acid uptakes in L6 myotubes. Mol Cell Bio-chem 2004;261:99-104. (Pubitemid 39004522)
47. Yamaguchi S, Katahira H, Ozawa S, Nakamichi Y, Tanaka T, Shimoyama T, Takashi K, Yoshimoto K, Imaizumi MO, Naga-matsu S, Ishida H: Activators of AMP-activated protein kinase enhance GLUT4 translocation and its glucose transport activity in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 2005; 289:E643-E649. (Pubitemid 41356086)
48. Rathi SS, Grover JK, Vats V: The effect of Momordica charantia and Mucuna pruriens in experimental diabetes and their effect on key metabolic enzymes involved in carbohydrate metabolism. Phytother Res 2002;16:236-243. (Pubitemid 34534949)
49. Hafizur RM, Kabir N, Chisti S: Modulation of pancreatic b-cells in neonatally streptozotocin-induced type-2 diabetic rats by the ethanolic extract of Momordica charantia fruit pulp. Nat Prod Res 2011;25:353-367.
50. Nafisa PC, Fernandes, Chkradhar VL, Vandana SP, Suresh RN: An experimental evaluation of the antidiabetic and antilipidemic properties of a standardized Momordica charantia fruit extract. BMC Complement Altern Med 2007;7:29.
51. Baizid AS, Liakot A, Rafiqur R: Hypoglycaemic activity of Coccinia indica and Momordica charantia in diabetic rats: depression of hepatic gluconeogenic enzymes glucose-6-phospha-tase and fructose-1,6-bisphosphatase and elevation of both liver and red-cell shunt enzyme glucose-6-phosphate dehydrogenase. Biochem J 1993;292:267-270.
52. Huang HL, Hong YW, Wong YH, Chen YN, Chyuan JH, Huang CJ, Chao PM: Bitter melon (Momordica charantia) inhibits ad-ipocyte hypertrophy and down regulates lipogenic gene expression in adipose tissue of diet-induced obese rats. Br J Nutr 2008;97:230-239.
53. Laureen LYC, Qixuan C, Adi GGG, Emily KYL, Edmund TSL: Reduced adiposity in bitter melon (Momordica charantia)-fed rats is associated with increased lipid oxidation enzyme activities and uncoupling protein expression. J Nutr 2005;135: 2517-2523.
54. Chao CY, Huang CJ: Bitter gourd (Momordica charantia) extract activates peroxisome proliferator-activated receptors and upre-gulates the expression of the acyl CoA oxidase gene in H11EC3 heptoma cells. J Biomed Sci 2003;10:782-791.
55. Matsuzawa Y, Funahasi T, Kihara S, Shimomura I: Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004; 24:29-33. (Pubitemid 38082408)
56. Masaki T, Chiba S, Yasuda T, Tsubare T, Kakuma T, Shimomum I, Funhashi T, Mertsuzawa Y, Yoshimatsu H: Peripheral but not central administration of adiponectin reduces visceral adiposity and upregulates the expression of uncoupling protein in aguti yellow (Ay/u) obese mice. Diabetes 2003;52:2266-2273. (Pubitemid 37059496)
57. HuE, Liang P, Spiegelman BM: Adipo Q is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996;271: 10697-10703. (Pubitemid 26145805)
58. Yamuchi P, Kaman J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tonrita M, Froguel P, Kadowaki T: The fat derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;7:941-946. (Pubitemid 32756432)
59. Abdollahi M, Zuki AB, Goh YM, Razaeizadeh A, Noordin MM: Effects of Momordica charantia on pancreatic histopathological changes associated with streptozotocin-induced diabetes in neonatal rats. Histol Histopathol 2011;26:13-21.
60. Singh N, Gupta M: Regeneration B-cells in islets of Langerhans of pancrease of alloxan diabetic rats by acetone extract of Mo-mordica charantia (Linn) (bitter gourd) fruits. Indian J Exp Biol 2007;45:1055-1062.
61. Xiang L, Huang X, Chen L, Rao P, Ke L: The reparative effects of Momordica charantia Linn extract on HIT-T15 pancreatic B-cells. Asia Pacific J Clin Nutr 2007;16:249-252. (Pubitemid 46524609)
62. Chaturvedi P: Bitter melon protects against lipid peroxidation caused due to immobilization stress in albino rats. Int J Vitamin Nutr Res 2009;79:48-56.
63. Chaturvedi P, George S: Momordica charantia maintains normal glucose levels and lipid profiles and prevents oxidative stress in diabetic rats subjected to chronic sucrose load. J Med Food 2010; 13:520-527.
64. Shih CC, Lin CH, Lin WL, Wu JB: Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose fed rats. J Ethnopharmacol 2009;123:82-99.
65. Winder WW, Hardie DG: AMP activated protein kinase, a metabolic master switch: possible role in type 2 diabetes. Am J Physiol 1999;277:1-10.
66. Klomann SD, Muellar AS, Pallauf J, Krawinkel MB: Anti-diabetic effects of bitter gourd extracts in insulin resistant db/db mice. Br J Nutr 2010;11:1613-1620.
67. 2+. Am J Physiol Endocrinol Metab 2002;282:E1008-E1013. (Pubitemid 34654713)
68. Sridhar MG, Vinayagamoorthi R, Arul Suyambunathan V, Bobby Z, Selvaraj N: Bitter gourd (Momordica charantia) improves insulin sensitivity by increasing skeletal muscle insulin-stimulated IRS-1 tyrosine phosphorylation in high-fat-fed rats. Br J Nutr 2008;99:806-812. (Pubitemid 351351634)
69. Nhiem NX, Kiem PV, Minh CV, Ban NK, Cuong NX, Tung NH, Hale M, Hado T, Tai BM, Quang TH, Ngoc TM, Kwon YI, Jang HD, Kim YH: a-Glucosidase inhibition of properties of cu-curbutane type triterpene glucosides from the fruit of Momordica charantia. Chem Pharm Bull 2010;58:720-724.
70. Hayashi T, Hirshman MF, Kurth EJ, Winder WW, Goodyear L: Evidence for 5 AMP activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 1998; 47:1369-1373. (Pubitemid 28357021)
71. Kubota N, Yano W, Yano W, Kubota T, Yamuchi T, Itoh S, Kumgari H, Kozono H, Takamoto I, Okomato S, Shiuchi T, Suzuki R, Satoh H, Tsuchida A, Moroi M, Sugi K, Noda T, Ebinuma H, Ueta Y, Kondo T, Araki E, Ezaki O, Nagai R, Tobe K, Terauchi Y, Ueki K, Minokoshi Y, Kadowaki T: Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab 2007;6:3-4.
72. Irrcher I, Walkinsaw DR, Sheehan TE, Hood DA: Thyroid hormone (T3) rapidly activates p38 and AMPK in skeletal muscle in vivo. J Appl Physiol 2008;104:178-185.
73. Branvold DJ, Allred DR, Beckstead DJ, Kim HJ, Fillmore N, Condon BM, Brown JD, Sudweeks SN, Thomson DN, Winder WW: Thyroid hormone effects on LKB1, MO25, phospho-AMPK, phospho-CREB, and PGC-1alpha in rat muscle. J Appl Physiol 2008;105:1218-1227.